Role of Phosphatidylinositol 3,4,5-Trisphosphate in Cell Signaling
Authors:
- 8 April 2013
- book chapter
- Published by Springer Nature
- Vol. 991, 105-139
Abstract
Many lipids present in cellular membranes are phosphorylated as part of signaling cascades and participate in the recruitment, localization, and activation of downstream protein effectors. Phosphatidylinositol (3,4,5)-trisphosphate (PtdIns(3,4,5)P3) is one of the most important second messengers and is capable of interacting with a variety of proteins through specific PtdIns(3,4,5)P3 binding domains. Localization and activation of these effector proteins controls a myriad of cellular functions including cell survival, proliferation, cytoskeletal rearrangement, and gene expression. Aberrations in the production and metabolism of PtdIns(3,4,5)P3 have been implicated in many human diseases including cancer, diabetes, inflammation, and heart disease. This chapter provides an overview of the role of PtdIns(3,4,5)P3 in cellular regulation and the implications of PtdIns(3,4,5)P3 dysregulation in human diseases. Additionally, recent attempts at targeting PtdIns(3,4,5)P3 signaling via small molecule inhibitors are summarized.Keywords
This publication has 273 references indexed in Scilit:
- Interplay between FOXO, TOR, and AktBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Akt, FoxO and regulation of apoptosisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- One lipid, multiple functions: how various pools of PI(4,5)P2 are created in the plasma membraneCellular and Molecular Life Sciences, 2010
- The hexosamine signaling pathway: O-GlcNAc cycling in feast or famineBiochimica et Biophysica Acta (BBA) - General Subjects, 2010
- AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human CancerCancer Cell, 2009
- Functional differences between two classes of oncogenic mutation in the PIK3CA geneBiochemical and Biophysical Research Communications, 2009
- Ischemia-reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiencyBasic Research in Cardiology, 2008
- A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin SignalingCell, 2006
- A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in gliomaCancer Cell, 2006
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsCancer Cell, 2004